ENTITY
Ensysce Biosciences

Ensysce Biosciences (ENSC US)

14
Analysis
Health Care • United States
Ensysce Biosciences, Inc. operates as a clinical stage biotech company. The Company focuses on stemming the prescription drug abuse epidemic. Ensysce Biosciences serves customers worldwide.
more
bullish•Ensysce Biosciences
•16 Aug 2024 01:00•Issuer-paid

ENSC: 2Q Release Sets Stage for Important Trials

Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...

Share
bullish•Ensysce Biosciences
•14 May 2024 00:00•Issuer-paid

ENSC: 1Q Release Highlights Financial and Scientific Progress

Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the...

Share
•21 Sep 2022 08:00•Issuer-paid

Mat-Chem Notes for the Week Ended September 18, 2022

KEY HIGHLIGHTS WTR-CMI last week. Reversing the prior week’s trend, the stock market pulled back last week following the release of disappointing...

Logo
839 Views
Share
•27 Jan 2020 21:42

MergerTalk: Game On For SPACs

Special Purpose Acquisition Companies or SPACs have been making a comeback in the last 3 years, but remain an underappreciated segment of the...

Logo
574 Views
Share
x